about
Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health scienceMolecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and diseaseEtiologic field effect: reappraisal of the field effect concept in cancer predisposition and progressionHow many molecular subtypes? Implications of the unique tumor principle in personalized medicineDiscovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiologyStatistical methods for studying disease subtype heterogeneityA conceptual and methodological framework for investigating etiologic heterogeneityProceedings of the second international molecular pathological epidemiology (MPE) meetingIdentifying Etiologically Distinct Sub-Types of Cancer: A Demonstration Project Involving Breast CancerIntegration of molecular pathology, epidemiology and social science for global precision medicine.Detecting and exploiting etiologic heterogeneity in epidemiologic studies.Age-associated gene expression in normal breast tissue mirrors qualitative age-at-incidence patterns for breast cancer.Null association between histology of first and second primary malignancies in men with bilateral testicular germ cell tumors.The diagnostic yield of fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography in recurrent testicular seminoma.Defining Cancer Subtypes With Distinctive Etiologic Profiles: An Application to the Epidemiology of Melanoma.Examining the common aetiology of serous ovarian cancers and basal-like breast cancers using double primaries.
P2860
Q24289208-50A29753-E14F-46F4-B614-6F942FBF4740Q24289344-D3BD8B94-4583-4D3C-AFA2-C1A8467D0A9FQ26852716-CCFF796D-D5ED-47FD-B065-D20861A643E4Q26992045-BFC62406-16E7-4507-9A18-751B879B86C7Q27011884-89822856-8815-486F-A793-204CACA47625Q28385063-A075A9D4-7205-4FBF-8C1B-4A4A78F99E63Q33923726-CB4BDEC5-7DC0-4231-A835-EC9046921DB3Q34475686-12CC4DF2-8F92-4DDD-961C-3C1F93DABE83Q36051807-113088C1-7C79-4157-8CC1-9B2338B10A78Q36463854-D57E0142-4735-44D2-B24C-DCFBD78C863EQ36489228-90F71D21-F368-4596-8992-937412D0724FQ36935007-39CBAA01-14B0-491F-A209-C48D241F8C92Q37220807-D4A9B83F-7380-44AF-AD50-CF9E8E8CAB32Q37400632-FCD3F2D4-9905-4E0B-A02F-788733719DA1Q38731109-C8579504-F743-4B78-BAE2-D489896108F4Q40277712-54D81A6B-8E6A-4D9F-9FA1-FB734341257B
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A strategy for distinguishing optimal cancer subtypes.
@ast
A strategy for distinguishing optimal cancer subtypes.
@en
A strategy for distinguishing optimal cancer subtypes.
@nl
type
label
A strategy for distinguishing optimal cancer subtypes.
@ast
A strategy for distinguishing optimal cancer subtypes.
@en
A strategy for distinguishing optimal cancer subtypes.
@nl
prefLabel
A strategy for distinguishing optimal cancer subtypes.
@ast
A strategy for distinguishing optimal cancer subtypes.
@en
A strategy for distinguishing optimal cancer subtypes.
@nl
P2860
P356
P1476
A strategy for distinguishing optimal cancer subtypes.
@en
P2093
Colin B Begg
P2860
P304
P356
10.1002/IJC.25714
P577
2010-11-18T00:00:00Z